Investor Intelligence

12 Medical Device Investors in Europe

European investors with demonstrated activity across medical devices, surgical technology, diagnostics and clinically integrated hardware.

Published 29 September 2026

Medical Devices
Medtech
Surgical Technology
Diagnostics
Europe
Seed
Series A

Medical-device investing in Europe spans specialist healthcare funds, deep-tech investors, public-backed venture capital and angel networks. The category combines regulated hardware, clinical evidence, reimbursement and commercial adoption, so relevant investors often bring more than general healthcare exposure.

DealBio selected 12 investors with evidenced relevance to medical devices in Europe, using current investor research, financing precedents and public verification where needed.

Empirical Ventures

Early-stage deep-science investor leading pre-seed and seed rounds in research-driven technology companies.

Stage: Pre-seed · Seed
Sector / Focus: Medical devices · Diagnostics · Therapeutics
Investment markets: United Kingdom · Europe
Investor type: VC

Relevant investment

Empirical Ventures invested in Silveray’s £4 million seed round in November 2024 and followed on in its £5 million 2026 financing. Silveray develops thin, flexible direct-conversion X-ray detectors with applications in medical imaging, giving Empirical a direct medical-device and imaging precedent.

EQT Life Sciences

European healthcare investor backing biotechnology, medical devices and other life-sciences companies from venture through growth.

Stage: Series A · Growth
Sector / Focus: Medical devices · Surgical technology · Healthcare AI
Investment markets: Europe
Investor type: VC

Relevant investment

EQT Life Sciences led Nua Surgical’s €6.5 million Series A in December 2024. Nua Surgical is developing SteriCISION, a self-retaining retractor designed specifically for Caesarean-section surgery, giving EQT a direct European medical-device precedent spanning regulatory approval and commercialisation.

HTGF

German early-stage investor backing technology and life-sciences companies from pre-seed through Series A.

Stage: Pre-seed · Seed · Series A
Sector / Focus: Medical devices · Surgical technology · Patient monitoring
Investment markets: Germany · Europe
Investor type: VC

Relevant investment

HTGF led Medical Decision Alliance’s €3.3 million seed round in May 2025. The company develops AI-based surgical assistance systems designed to capture expert surgical decision-making and integrate it with operating-room technology, giving HTGF a recent medtech precedent at the intersection of medical devices, surgical robotics and clinical software.

Bayern Kapital

Bavarian venture investor supporting technology companies from seed through growth, including healthcare and medtech.

Stage: Pre-seed · Seed · Series A
Sector / Focus: Medical devices · Medical imaging · Diagnostics
Investment markets: Germany
Investor type: VC

Relevant investment

Bayern Kapital participated in Symphera’s €2.4 million seed round in September 2024. Symphera is developing a medical-device system that automates instrument changes during laparoscopic surgery, giving Bayern Kapital direct exposure to early-stage surgical technology and regulated medtech.

IXcore

French healthcare investor backing early-stage medical technologies, diagnostics and imaging companies.

Stage: Pre-seed · Seed · Series A
Sector / Focus: Medical devices · Drug delivery · Biomaterials
Investment markets: France
Investor type: VC

Relevant investment

IXcore backed Chipiron, a French company developing compact MRI systems designed to reduce the size, infrastructure requirements and cost of conventional magnetic-resonance imaging. The investment gives IXcore direct exposure to regulated medical imaging hardware and non-invasive diagnostics.

UI Investissement

French investment firm with dedicated healthcare activity across innovation, growth and regional investment strategies.

Stage: Seed · Series A
Sector / Focus: Medical devices · Medical imaging · Surgical technology
Investment markets: France · Europe
Investor type: VC

Relevant investment

UI Investissement’s Majycc Innovation Santé strategy co-led Brightflow’s €16.5 million Series A in September 2024. Brightflow is developing a fully percutaneous long-term right-ventricular assist device for severe heart failure, giving UI a direct cardiovascular-medtech precedent.

Venture Kick

Swiss startup initiative providing staged early funding and investor access to university-linked technology companies.

Stage: Pre-seed · Seed
Sector / Focus: Medical devices · Neurotechnology · Ophthalmology
Investment markets: Switzerland
Investor type: Startup funding initiative

Relevant investment

Venture Kick supported Positrigo from its early development and the company later raised CHF 7 million in 2025 to expand production of NeuroLF, its cleared compact brain-PET imaging system. The precedent shows Venture Kick’s role in moving Swiss university medtech from early support toward regulatory and commercial milestones.

SICTIC

Swiss angel-investor network backing early-stage technology companies, including healthtech and medical devices.

Stage: Pre-seed · Seed
Sector / Focus: Medical devices · Neurotechnology · Ophthalmology
Investment markets: Switzerland
Investor type: Angel network

Relevant investment

SICTIC backed PeriVision, a Swiss ophthalmology company developing digital visual-field testing and eye-care technology. The investment provides a direct early-stage medical-device and ophthalmology precedent from SICTIC’s healthtech activity.

Panakès Partners

Specialist European life-sciences VC investing in medtech, diagnostics, biotechnology and digital therapeutics.

Stage: Seed · Series A
Sector / Focus: Medical devices · Medtech
Investment markets: Belgium · Europe
Investor type: VC

Relevant investment

Panakès Partners participated in Endovascular Engineering’s $42 million Series B in February 2025. The company is developing the Hēlo thrombectomy system for pulmonary embolism, giving Panakès a direct interventional-medtech precedent in cardiovascular devices.

White Fund

Belgian early-stage investment fund dedicated exclusively to medical-device companies.

Stage: Seed · Series A
Sector / Focus: Medical devices · Medtech
Investment markets: Europe
Investor type: VC

Relevant investment

White Fund invested in Axithra’s €10 million seed round. Axithra is developing a rapid therapeutic-drug-monitoring platform for measuring medicine concentrations in blood and adjusting doses, giving White Fund a direct Belgian medtech precedent spanning diagnostics and regulated product development.

GEO MedTech Ventures

Specialist medtech investor focused on medical-device companies with clear clinical and commercial pathways.

Stage: Seed · Series A
Sector / Focus: Medical devices · Medtech
Investment markets: Europe
Investor type: VC

Relevant investment

GEO MedTech Ventures led a $2 million Series A investment in Aqua Therapeutics. The company is developing an office-based medical-device treatment for abnormal uterine bleeding, giving GEO a direct device precedent from feasibility studies toward clinical development.

Mérieux Equity Partners

Healthcare and nutrition investment manager backing venture and growth companies across Europe and North America.

Stage: Series A · Growth
Sector / Focus: Medical devices · Medtech
Investment markets: Europe
Investor type: VC / Growth investor

Relevant investment

Mérieux Equity Partners co-led HighLife Medical’s $90+ million financing in September 2026. HighLife develops transcatheter mitral-valve replacement technology for structural heart disease, giving Mérieux a direct European medtech precedent spanning clinical development and commercial expansion.

Methodology

DealBio builds investor lists using structured investor research, demonstrated investment activity and current public verification where needed. The methodology highlights investors with evidenced relevance to the article’s sector, stage and geography.

Relevant investment

Relevant investment

Relevant investment

Relevant investment

Relevant investment

Relevant investment

Relevant investment

Relevant investment

Relevant investment

Relevant investment

Relevant investment

Relevant investment

Methodology

Get the DealBio Pulse